Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Central Europe Online .
Press releases published on May 20, 2025

Secure Your Crypto Earnings with Za Miner: A Smarter Alternative to Risky Exchanges
London, UK, May 20, 2025 (GLOBE NEWSWIRE) -- Coinbase recently confirmed a data breach and that customer data, such as government-issued identity documents, was stolen. CEO Brian Amstrong confirmed on an X (formally Twitter) post on May 15 that a hacker …

XRP Price Prediction: Ripple is expected to break through $5 after a sharp correction and bullish signals, smart investors choose to invest in KSDMiner to earn passive incomee
Los Altos, California, May 20, 2025 (GLOBE NEWSWIRE) -- Currently, XRP is trading at around $2.53, just below recent highs. The pullback coincides with a broader market pullback like Bitcoin and Ethereum. Market analysts say XRP is still poised for further …

Result of AGM
SHELL PLC RESULT OF ANNUAL GENERAL MEETING Shell plc (Shell) announces the poll results on the resolutions at its Annual General Meeting held on Tuesday May 20, 2025 at the Sofitel London Heathrow Hotel Terminal 5, London Heathrow Airport, London TW6 2GD. …

Helix and Avalanche Announce $100M Commitment to Support Fusion, A New Framework for Blockchain Economies Focused on Real-World Outcomes
The initiative supports new Layer 1 networks and on-chain services designed for practical applications across sectors such as AI, healthcare, and decentralized infrastructure LONDON, May 20, 2025 (GLOBE NEWSWIRE) -- Helix and Avalanche, with support from …

QCT Announces Support for AMD Instinct™ MI350 Series GPUs and Platforms at COMPUTEX 2025
Company presents QuantaGrid servers with AMD compatibility to meet the growing demands of AI TAIPEI, TAIWAN, May 20, 2025 /EINPresswire.com/ -- Quanta Cloud Technology (QCT), a leading provider of data center and AI solutions, today announced support …

QCT Showcases Data Center, Cloud, and HPC Products and AI Compute Solutions
Based on Intel® Xeon® 6 and Intel® Gaudi® 3 AI Accelerators with OPEA TAIPEI, TAIWAN, May 20, 2025 /EINPresswire.com/ -- Quanta Cloud Technology (QCT), a leading provider of data center solutions, is showcasing products and solutions powered by Intel® …

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts
Vancouver, Canada, May 20, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve …

PFMcrypto Introduces Flexible 1-Day Income Plan, Making Bitcoin Mining Accessible
New York City, May 20, 2025 (GLOBE NEWSWIRE) -- Faced with the dual burden of market instability and high hurdles in traditional finance, more and more investors are turning to cloud computing leasing as a stable source of income. PFMcrypto, a digital …

Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being ‘Ms. Represented’ in First-of-its-Kind Campaign with Supernus Pharmaceuticals
Females with ADHD frequently present with inattentive symptoms, which can be more difficult to recognize than the hyperactive and impulsive symptoms more often seen in males Boys are two times more likely to be diagnosed with ADHD than girls, leaving many …

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake
SEATTLE and VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …

Mersana Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., May 20, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, …

Sono Group N.V. Reports First Quarter 2025 Results with €8.8 Million Net Income
MUNICH, May 20, 2025 (GLOBE NEWSWIRE) -- Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono” or the “Company”, parent company to Sono Motors GmbH or “Sono Motors”), the solar technology company, today announced its financial results for the …

Only 1 in 100 insurers say Claims-Finance Collaboration is “highly effective”, new research by Vitesse finds
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- Vitesse, the trusted financial infrastructure connecting the global insurance ecosystem, today released a new research report: The State of Claims Finance: Tackling Roadblocks in Payments, Liquidity and Financial …

Reflect Scientific Receives Over $250,000 in New Orders for High-Performance Freezers from International Biotech and Pharma Clients
OREM, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of advanced cryogenic and refrigeration technologies, announced today it has received over $250,000 in new orders for its high-performance freezer systems. The …

Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

Enlivex Selected to Present at Israeli BioMed 2025 Conference
Presentation to highlight Allocetra™ and the therapeutic potential of macrophage reprogramming in inflammatory diseases Ness-Ziona, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage …

SELLAS Life Sciences to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …

PDS Biotech to Participate at the A.G.P. Virtual Annual Healthcare Company Showcase
PRINCETON, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …

Praxis Precision Medicines to Participate in Upcoming Conferences
BOSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis
NIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch biotechnology company developing antibody-based therapies to treat severe immune disorders, today announced that it has enrolled the first patient in a Phase 1/2 clinical …